Delivery Order SPE2DB22D3009-SPE2DB25FBF55
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,406.50 to AmerisourceBergen Drug Corp for the supply of Omeprazole DR 40 mg capsules (1,000 count) with a firm fixed price structure. The contract, awarded on September 11, 2025, with an ultimate completion date of September 12, 2025, represents a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its...
- The Defense Logistics Agency awarded a delivery order valued at $1,067.39 to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Omeprazole DR 40 mg capsules (1,000 count). This competitively awarded, firm fixed-price contract involves no set-aside designation and is scheduled for completion by September 26, 2025. The pharmaceutical product will be delivered to the awardee's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency awarded a $1,028.23 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Omeprazole DR 40 mg capsules in a quantity of 500 units. This non-competitive delivery order, issued on September 10, 2025, with an ultimate completion date of September 11, 2025, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract action under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,256.67 to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Omeprazole DR 20 mg capsules (1,000 units). This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of August 6, 2025, to be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, fulfills this...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Omeprazole DR 20 mg capsules (1,000 count) with a contract ceiling value of $1,792.19. This firm fixed-price delivery order, with an ultimate completion date of September 8, 2025, will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The award was made without set-aside restrictions, indicating competitive procurement. This delivery...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation, to provide 1,000 capsules of 40 mg Omeprazole DR for $6,277.53. This order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded by DLA to Amerisourcebergen Drug Corp to deliver a comprehensive range of pharmaceutical products and medical supplies to...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distributor. The $1,294.37 contract is for the delivery of 1,000 units of 40 milligram omeprazole delayed release capsules, with a completion date of February 7, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA Troop Support Medical,...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,815.85 Firm Fixed Price Delivery Order is for the supply of 500 units of Omeprazole DR 40 mg capsules, with a period of performance through August 18, 2022. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, providing a comprehensive...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,566,803 units of the prescription drug Omeprazole DR 20 mg Capsule, with a ceiling value of $1,095.82 and a completion date of December 30, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
- This is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp., a major pharmaceutical distributor, for the supply of 4,561,523,191 units of Omeprazole DR 10 mg capsules. The $3,844.89 firm fixed-price contract has a completion date of July 18, 2023 and was awarded on July 17, 2023. It is not designated as a set-aside contract. The contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA...
- SPE2DB22D3009Indefinite Delivery Contract
- SPE2DB22D3009-SPE2DB25FBF55Delivery Order
The Defense Logistics Agency (DLA) awarded a $9,259.35 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of 1,000 omeprazole DR 40 mg capsules, with a completion date of September 26, 2025. This non-set-aside contract was competitively awarded and represents a routine pharmaceutical procurement to support federal medical supply needs. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical prime vendor vehicle valued at $999,999,999.00 and extending through December 2026. The IDC enables AmerisourceBergen to deliver a broad range of pharmaceutical products and medical supplies to support military healthcare systems globally, including the Defense Health Agency, U.S. Coast Guard, and other federal healthcare entities. The company's demonstrated capability to supply critical medications across multiple therapeutic domains through competitive awards positions it as a key supplier within the DLA's medical supply chain infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.3k | 9/25/25 |